UnitedHealth Group (UNH)
(Delayed Data from NYSE)
$615.81 USD
+10.36 (1.71%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $616.22 +0.41 (0.07%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
UnitedHealth Group (UNH) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$625.79 | $715.00 | $595.00 | 3.36% |
Price Target
Based on short-term price targets offered by 24 analysts, the average price target for UnitedHealth Group comes to $625.79. The forecasts range from a low of $595.00 to a high of $715.00. The average price target represents an increase of 3.36% from the last closing price of $605.45.
Analyst Price Targets (24)
Broker Rating
UnitedHealth Group currently has an average brokerage recommendation (ABR) of 1.14 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 25 brokerage firms. The current ABR compares to an ABR of 1.06 a month ago based on 25 recommendations.
Of the 25 recommendations deriving the current ABR, 22 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 88% and 8% of all recommendations. A month ago, Strong Buy made up 92%, while Buy represented 8%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 22 | 22 | 23 | 22 | 23 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 1 | 1 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.14 | 1.14 | 1.06 | 1.06 | 1.06 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
11/4/2024 | Wells Fargo Securities | Stephen Baxter | Strong Buy | Strong Buy |
10/22/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
10/18/2024 | Cowen & Co. | Ryan Langston | Strong Buy | Strong Buy |
10/17/2024 | Not Identified | Not Identified | Strong Buy | Hold |
10/16/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
10/16/2024 | Cantor Fitzgerald & Co | Sarah James | Strong Buy | Strong Buy |
10/16/2024 | Stephens | Scott Fidel | Strong Buy | Strong Buy |
10/16/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
10/16/2024 | Truist Securities | David S Macdonald | Strong Buy | Strong Buy |
10/16/2024 | SVB Securities | Whit Mayo | Strong Buy | Strong Buy |
10/15/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
10/10/2024 | KeyBanc Capital Markets | Matthew Gillmor | Not Available | Strong Buy |
9/23/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/16/2024 | Mizuho SecuritiesUSA | Ann K Hynes | Strong Buy | Strong Buy |
7/18/2024 | UBS | Kevin Caliendo | Strong Buy | Strong Buy |
7/17/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/17/2024 | Argus Research Corp. | David A Toung | Not Available | Strong Buy |
7/17/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/30/2024 | Robert W. Baird & Co. | Michael Ha | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.14 |
ABR (Last week) | 1.14 |
# of Recs in ABR | 25 |
Average Target Price | $625.79 |
LT Growth Rate | 12.30% |
Industry | Medical - HMOs |
Industry Rank by ABR | 183 of 252 |
Current Quarter EPS Est: | 6.76 |
UNH FAQs
UnitedHealth Group Incorporated (UNH) currently has an average brokerage recommendation (ABR) of 1.14 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 25 brokerage firms.
The average price target for UnitedHealth Group Incorporated (UNH) is $625.79. The current on short-term price targets is based on 15 reports.
The forecasts for UnitedHealth Group Incorporated (UNH) range from a low of $595 to a high of $715. The average price target represents a increase of $3.36 from the last closing price of $605.45.
The current UPSIDE for UnitedHealth Group Incorporated (UNH) is 3.36%
Based on short-term price targets offered by 24 analysts, the average price target for UnitedHealth Group comes to $625.79. The forecasts range from a low of $595.00 to a high of $715.00. The average price target represents an increase of 3.36% from the last closing price of $605.45.